AZTA · Azenta, Inc. · Webcasts, Transcripts & Audio
$48.55
-0.14 (-0.29%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q4 2026 earnings call transcript
Market Cap
$2.13B
Shares
43.81M
Volume · Nov 19
601.54K
Avg daily vol (3M)
1.03M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Azenta, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Azenta, Inc. (AZTA), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-30
Azenta, Inc. (AZTA) November 30, 2026 Conference
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q4
2026-11-11
Azenta, Inc. (AZTA) Q4 2026 Earnings Call Transcript
Confident tone
Multi-omics repositioning and growth
Restructuring and productivity
Legacy Sanger sequencing headwind
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY26 · Q3
2026-08-05
Azenta, Inc. (AZTA) Q3 2026 Earnings Call Transcript
Positive tone
Multi-omics turnaround
Regional performance — China and Europe
Fiscal 2026 outlook and Q4 guidance
Revenue
$161.18M
▲ 12% YoY Diluted EPS
$0.05
Gross margin
44.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-05-06
Azenta, Inc. (AZTA) Q2 2026 Earnings Call Transcript
Cautious tone
Gene synthesis and next-gen sequencing strategy
Revised FY2026 outlook
Multiomics transformation under new leadership
Revenue
$144.79M
▲ 1% YoY Diluted EPS
$-3.49
Gross margin
42.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-03
Azenta, Inc. (AZTA) March 3, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-02-04
Azenta, Inc. (AZTA) Q1 2026 Earnings Call Transcript
Positive tone
Turnaround execution and operational excellence
Margin expansion and cost actions
Sample management and biorepositories
Revenue
$148.64M
▲ 0.8% YoY Diluted EPS
$-0.34
Gross margin
42.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2025-11-21
Azenta, Inc. (AZTA) Q4 2025 Earnings Call Transcript
Confident tone
Capital deployment priorities: M&A focus areas
Capital allocation and balance sheet flexibility
Fiscal 2025 financial results and margin expansion
Revenue
$159.19M
▲ 5.7% YoY Diluted EPS
$1.11
Gross margin
45.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-08-05
Azenta, Inc. (AZTA) Q3 2025 Earnings Call Transcript
Positive tone
Growth priorities and innovation
Operational turnaround and cost discipline
Next-gen sequencing and core lab strength
Revenue
$143.85M
▼ 0.3% YoY Diluted EPS
$-1.05
Gross margin
46.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-05-07
Azenta, Inc. (AZTA) Q2 2025 Earnings Call Transcript
Positive tone
Multiomics and Next Gen Sequencing
Organic Growth and Financial Performance
Macro Uncertainty and Tariffs
Revenue
$143.34M
▲ 5.1% YoY Diluted EPS
$-1.04
Gross margin
43.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-02-05
Azenta, Inc. (AZTA) Q1 2025 Earnings Call Transcript
Positive tone
Multiomics business (NGS, Sanger, ONT)
Gene Synthesis positioning and capacity
Full-year 2025 guidance reiteration
Revenue
$147.44M
▲ 3.7% YoY Diluted EPS
$-0.25
Gross margin
46.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-11-12
Azenta, Inc. (AZTA) Q4 2024 Earnings Call Transcript
Positive tone
Multiomics growth and pricing
Ascend 2026 and margin expansion
Sample Management Solutions and automation
Revenue
$150.60M
▲ 156.3% YoY Diluted EPS
$-0.14
Gross margin
45.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-08-06
Azenta, Inc. (AZTA) Q3 2024 Earnings Call Transcript
Confident tone
Multiomics / NGS (Next-Generation Sequencing) business
Ascend 2026 profitability and cost transformation program
Quarterly financial performance and organic growth
Revenue
$144.29M
▼ 13% YoY Diluted EPS
$-0.12
Gross margin
44.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-05-08
Azenta, Inc. (AZTA) Q2 2024 Earnings Call Transcript
Positive tone
B Medical Sciences and vaccine cold chain
Multiomics and Next Generation Sequencing
China outperformance
Revenue
$136.35M
▼ 8.1% YoY Diluted EPS
$-2.48
Gross margin
43.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-02-07
Azenta, Inc. (AZTA) Q1 2024 Earnings Call Transcript
Positive tone
FY2024 guidance and B Medical ramp
Q1 results and organic revenue decline
Multiomics and next-generation sequencing
Revenue
$142.20M
▼ 20.3% YoY Diluted EPS
$-0.25
Gross margin
43.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-11-13
Azenta, Inc. (AZTA) Q4 2023 Earnings Call Transcript
Revenue
$58.77M*
▼ 57.3% YoY Gross margin
75.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-08-08
Azenta, Inc. (AZTA) Q3 2023 Earnings Call Transcript
Revenue
$165.95M
▲ 25% YoY Diluted EPS
$-0.02
Gross margin
41.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-05-09
Azenta, Inc. (AZTA) Q2 2023 Earnings Call Transcript
Revenue
$148.40M
▲ 2% YoY Diluted EPS
$-0.07
▼ 100.2% YoY Gross margin
35.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-02-08
Azenta, Inc. (AZTA) Q1 2023 Earnings Call Transcript
Revenue
$178.37M
▲ 27.7% YoY Diluted EPS
$-0.15
▼ 125.9% YoY Gross margin
41.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-11-14
Azenta, Inc. (AZTA) Q4 2022 Earnings Call Transcript
Revenue
$137.57M*
▲ 0.5% YoY Gross margin
42.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-07-13
Azenta, Inc. (AZTA) Q3 2022 Earnings Call Transcript
Revenue
$132.74M
▲ 2.8% YoY Diluted EPS
$-0.13
▼ 124.5% YoY Gross margin
44.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-05-09
Azenta, Inc. (AZTA) Q2 2022 Earnings Call Transcript
Revenue
$145.54M
▲ 12.4% YoY Diluted EPS
$28.28
▲ 8737.5% YoY Gross margin
48.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-02-08
Azenta, Inc. (AZTA) Q1 2022 Earnings Call Transcript
Revenue
$139.65M
▲ 18.2% YoY Diluted EPS
$0.58
▲ 65.7% YoY Gross margin
48.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-11-10
Azenta, Inc. (AZTA) Q4 2021 Earnings Call Transcript
Revenue
$136.94M
▲ 26.5% YoY Diluted EPS
$0.29
▼ 25.6% YoY Gross margin
48.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-08-05
Azenta, Inc. (AZTA) Q3 2021 Earnings Call Transcript
Revenue
$129.09M
▲ 38.4% YoY Diluted EPS
$0.53
▲ 178.9% YoY Gross margin
48.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-05-10
Azenta, Inc. (AZTA) Q2 2021 Earnings Call Transcript
Revenue
$129.53M
▲ 35.9% YoY Diluted EPS
$0.32
▲ 166.7% YoY Gross margin
44.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-02-02
Azenta, Inc. (AZTA) Q1 2021 Earnings Call Transcript
Revenue
$118.14M
▲ 28.9% YoY Diluted EPS
$0.35
▲ 94.4% YoY Gross margin
48.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-11-10
Azenta, Inc. (AZTA) Q4 2020 Earnings Call Transcript
Revenue
$108.25M
Diluted EPS
$0.39
Gross margin
48.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-07-30
Azenta, Inc. (AZTA) Q3 2020 Earnings Call Transcript
Revenue
$93.30M
▼ 54.2% YoY Diluted EPS
$0.19
▲ 90% YoY Gross margin
42.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-04-13
Azenta, Inc. (AZTA) Q2 2020 Earnings Call Transcript
Revenue
$95.30M
▼ 52% YoY Diluted EPS
$0.12
▲ 140% YoY Gross margin
43.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-02-06
Azenta, Inc. (AZTA) Q1 2020 Earnings Call Transcript
Revenue
$91.69M
▼ 48.9% YoY Diluted EPS
$0.18
▼ 10% YoY Gross margin
42.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–30 of 30 webcasts
Key facts
CIK
933974
CUSIP
114340102
13F (30d)
290 filings
251 filers
Visit website
Investor relations